This site is intended for healthcare professionals
Chronic Spontaneous Urticaria
Chronic Spontaneous Urticaria Learning Zone
Declaration of sponsorship Novartis Pharma AG and J. Uriach y Compañía S.A

CSU Symposium at EAACI 2023*

Declaration of sponsorship Novartis Pharma AG and J. Uriach y Compañía S.A
Read time: 5 mins
Last updated:3rd Apr 2023
Published:3rd Apr 2023

From Past to Present: What’s next for CSU?

Friday, 9 June 2023: 15:45–16:45 CEST

Agenda Friday, 9 June 2023
15:45 pm Welcome and introductions
Dr Clive Grattan
15:50 pm Exploring the Past: Approaches to CSU Care
Dr Clive Grattan
16:05 pm Current Guidelines in CSU Management
Professor Emek Kocatürk Göncü
16:20 pm What's New in Management: Future of Personalised Medicine
Professor Dr. Martin Metz
16:35 pm Q&A and panel discussion
Chaired by Dr Clive Grattan
16:45 pm Closing statement
Dr Clive Grattan

Have you registered for this symposium focused on improving the patient experience and exploring the development in the management of CSU patients? This live symposium will provide insight into emerging approaches to improve the diagnosis and treatment of chronic spontaneous urticaria (CSU) in the current guidelines. Discover the change in managing CSU patients, identify the advances in classification of CSU, and distinguish the differences in treatment options available for personalised medicine. During the event, you will be able to participate in a Q&A session and listen to a panel discussion in which experts provide insights based on their own clinical experience.

To attend this event live, you must register directly with EAACI. Click here to register now!

Not able to join live? Sign up on the form below to get involved by submitting your questions to the experts, and receive an email when this symposium is published on Medthority to receive your CME credit!*

Optional: I confirm that I am happy to receive relevant Medthority updates by email
An error has occurred while getting captcha image

This symposium aims to explore and broaden your current understanding in several key areas when treating patients with CSU. Through attending this symposium, you will gain 1 CME-CPD point through EACCME®*

After participating in this educational programme, learners will be able to:

  • Recognise the advancement in clinical practice for the management of CSU
  • Identify the advances in classification of CSU according to current guidelines
  • Distinguish the differences in treatment options available for personalised medicine

Professor Alexandra SantosDr Clive Grattan

Dr Clive Grattan is a consultant dermatologist at Guy’s and St Thomas’ Hospitals, London, UK.

Disclosures: Dr Clive Grattan is in receipt of honoraria or consultation fees from Novartis, Sanofi, Celltrion, Argenx, and Blueprint

Doctor Rebecca Knibb.pngProfessor Emek Kocatürk

Emek Kocatürk is Professor at the Department of Dermatology, Koç University School of Medicine, Istanbul, Turkey.

Disclosures: Speaker and advisor for Novartis, Menarini, LaRoche Posey, Sanofi, Bayer

Pablo Rodríguez del Río.pngProfessor Dr. Martin Metz

Prof. Dr Martin Metz is a Professor of Dermatology at the Institute of Allergology at the Charité – Universitätsmedizin and Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Allergology and Immunology, Berlin, Germany.

Disclosures: Prof. Dr Martin Metz is in receipt of honoraria or consultation fees from Amgen, AstraZeneca, Argenx, Celidex Therapeutics, Escientpharma, Jasper Therapeutics, Novartis, Pharvaris, Sanofi-Aventis, ThirdHarmonicBio

*This event is accredited under the Hamburg Medical Association and EACCME®.